These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19700570)

  • 1. "Temporal clustering" of COPD exacerbations may reflect corticosteroid withdrawal.
    MacDonald M; Bardin P
    Am J Respir Crit Care Med; 2009 Sep; 180(5):482-3; author reply 483. PubMed ID: 19700570
    [No Abstract]   [Full Text] [Related]  

  • 2. COPD exacerbations: 5 days of corticosteroid therapy.
    Prescrire Int; 2014 Oct; 23(153):246-7. PubMed ID: 25964977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Real-life" inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD.
    Vogelmeier C; Worth H; Buhl R; Criée CP; Lossi NS; Mailänder C; Kardos P
    Int J Chron Obstruct Pulmon Dis; 2017; 12():487-494. PubMed ID: 28203072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic corticosteroids during acute COPD exacerbations].
    Mal H
    Rev Mal Respir; 2017 Apr; 34(4):403-407. PubMed ID: 28455140
    [No Abstract]   [Full Text] [Related]  

  • 5. Corticosteroid Faceoff: Which is best for treating asthma and COPD exacerbations?
    Heuser W; Menaik R; Gupta S; Rucco R
    JEMS; 2017 May; 42(5):19-21. PubMed ID: 29227587
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.
    Singh JM; Palda VA; Stanbrook MB; Chapman KR
    Arch Intern Med; 2002 Dec 9-23; 162(22):2527-36. PubMed ID: 12456224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts.
    Lee SH; Lee JH; Yoon HI; Park HY; Kim TH; Yoo KH; Oh YM; Jung KS; Lee SD; Lee SW
    Respir Res; 2019 Mar; 20(1):62. PubMed ID: 30922302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care management of chronic obstructive pulmonary disease to reduce exacerbations and their consequences.
    Anzueto A
    Am J Med Sci; 2010 Oct; 340(4):309-18. PubMed ID: 20625276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis.
    Hinds DR; DiSantostefano RL; Le HV; Pascoe S
    BMJ Open; 2016 Jun; 6(6):e010099. PubMed ID: 27251682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is COPD in its age of enlightenment?
    Jenkins C
    Lancet Respir Med; 2014 Dec; 2(12):960-2. PubMed ID: 25466346
    [No Abstract]   [Full Text] [Related]  

  • 12. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids in COPD: quantifying risks and benefits.
    Cates C
    Thorax; 2013 Jun; 68(6):499-500. PubMed ID: 23242950
    [No Abstract]   [Full Text] [Related]  

  • 14. Daily home-based spirometry during withdrawal of inhaled corticosteroid in severe to very severe chronic obstructive pulmonary disease.
    Rodriguez-Roisin R; Tetzlaff K; Watz H; Wouters EF; Disse B; Finnigan H; Magnussen H; Calverley PM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1973-81. PubMed ID: 27578972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.
    Wood-Baker R; Walters J; Walters EH
    Respir Med; 2007 Mar; 101(3):371-7. PubMed ID: 16962307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of corticosteroids on exacerbations of asthma and chronic obstructive pulmonary disease.
    Calverley PM
    Proc Am Thorac Soc; 2004; 1(3):161-6. PubMed ID: 16113429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sputum inflammation predicts exacerbations after cessation of inhaled corticosteroids in COPD.
    Liesker JJ; Bathoorn E; Postma DS; Vonk JM; Timens W; Kerstjens HA
    Respir Med; 2011 Dec; 105(12):1853-60. PubMed ID: 21802933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
    Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
    Ding B; Small M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.